NATIXIS_REGISTRATION_DOCUMENT_2017

5 FINANCIAL DATA

Consolidated financial statements and notes

Goodwill 6.12

DECEMBER 31, 2017 R

01.01.2017

12.31.2017

Acquisitions during the

Reclassification and other activity

Opening balance

Translation adjustments

Closing balance

period Disposals Write-downs

(in millions of euros)

Asset & Wealth Management  (a) (b)

3,073 3,001

104 104

(191) (191)

2,986 2,914

Asset Management Wealth management

72 87 87 93 64 31 12 10

72 77 77 93 31 12 10

Corporate & Investment Banking Strategic and Acquisition Finance

(10) (10)

Insurance  (a)

Specialized Financial Services  (c) Employee Savings Schemes Sureties & Financial Guarantees

98

163

Consumer Finance

Payments Factoring

6 6

98

104

6

Coface

282

(1)

281

Corporate Center (excluding Coface)

0

0

TOTAL 3,601 Under the new strategic plan, New Dimension (see Note 9), and in line with the creation of the new Insurance business line, the Investment (a) Solutions CGU was split into two separate CGUs: “Asset & Wealth Management” and “Insurance”. Goodwill associated with the entities comprising the “Asset & Wealth Management” and “Insurance” Divisions was mainly reallocated to these two new CGUs according to the entities to which they report, with each entity assigned to only one CGU; Including €3.2 million for the goodwill recorded on the acquisition of Althelia Ecosphere. (b) Including €100.4 million for the goodwill recorded on the acquisition of Investor Mutual Limited. Including €11.8 million in goodwill recorded on the acquisition of Lakooz by S-Money, €14.3 million on the acquisition of PayPlug and €72.3 million (c) 3,600 202 (201)

on the acquisition of Fintech Dalenys. These four companies specialize in new online payment methods. Goodwill on entities consolidated using the equity method amounted to €3.2 million at December 31, 2017.

Certain goodwill recorded on the United States gives rise to a tax amortization over 15 years due to the difference between the book value of the goodwill and its fiscal value. This difference in treatment generated a deferred tax liability of €310.8 million as at December 31, 2017.

272

Natixis Registration Document 2017